The Life Science Group Sartorius today launched the new Octet ® SF3, the first Surface Plasmon Resonance (SPR) system under the Sartorius Octet ® brand. Up to now, the Octet ® name has been synonymous ...

Protein-based therapeutics play a crucial role in drug development and require the identification of therapeutic targets. Drug development using protein-based therapies is crucial in medical research ...

Innovative label-free technologies such as biolayer interferometry (BLI) and advances in biosensor technology over the past several years have been addressing the growing demand and requirements for ...

Real-time, label-free binding analysis is often viewed incorrectly as an ‘art’ instead of a ‘science’. The Octet® SF3 system challenges this notion through user-friendly technology. The field of ...